Fondaparinux Sodium Mechanism of Action
- 1 January 2002
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 41 (2), 11-18
- https://doi.org/10.2165/00003088-200241002-00002
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Fondaparinux SodiumDrugs, 2002
- The Pharmacokinetics of Fondaparinux Sodium in Healthy VolunteersClinical Pharmacokinetics, 2002
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture SurgeryNew England Journal of Medicine, 2001
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee SurgeryNew England Journal of Medicine, 2001
- A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 2001
- Age-Related Changes in Protein Binding of DrugsClinical Pharmacokinetics, 2000
- Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgeryBlood Coagulation & Fibrinolysis, 1998
- New Antithrombotic Agents For The Prevention And Treatment Of Deep Vein ThrombosisPathophysiology of Haemostasis and Thrombosis, 1996
- Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.BMJ, 1991
- Problems in Therapeutic Drug MonitoringTherapeutic Drug Monitoring, 1988